Milk ingredients have potential for psychiatric and diabetes treatments
Massachusetts-based biotechnology company Lactocore Group said it has identified novel milk-derived peptides that hold potential for developing safer and more effective treatments for a range of common psychiatric, metabolic and cognitive disorders.